Affiliation:
1. Revvity Inc. Lafayette Colorado
2. UPM Kymmene Corporation Helsinki Finland
Abstract
AbstractCell culture has long been essential for preclinical modeling of human development and disease. However, conventional two‐dimensional (2D) cell culture fails to faithfully model the complexity found in vivo, and novel drug candidates that show promising results in 2D models often do not translate to the clinic. More recently, three‐dimensional (3D) cell culture models have gained popularity owing to their greater physiological relevance to in vivo biology. In particular, 3D spheroid models are becoming widely used due to their ability to mimic solid tumors, both in architecture and gradation of nutrients distributed from the outer, proliferative layers into the inner, quiescent layers of cells. Similar to in vivo tumors, cell lines grown in 3D spheroid models tend to be more resistant to antitumor drug treatments than their 2D cultured counterparts, though distinct signaling pathways and gene targets conferring this resistance have yet to be fully explored. RNA interference (RNAi) is an effective tool to elucidate gene function and discover novel druggable targets in 2D models; however, only a few studies have successfully performed RNAi in complex 3D models to date. Here, we demonstrate efficient RNAi‐mediated knockdown using “transfection‐free” Dharmacon Accell siRNAs in three spheroid culture models, in the presence or absence of the extracellular matrix. This methodology has the potential to be scaled up for complex arrayed screening experiments, which may aid in the identification of novel druggable targets with greater clinical relevance than those identified in 2D experiments. © 2024 Dharmacon, Inc. Current Protocols published by Wiley Periodicals LLC.Basic Protocol 1: Generation of 3D spheroids in matrix‐free ULA platesAlternate Protocol 1: Generation of Matrigel matrix–embedded 3D spheroidsAlternate Protocol 2: Generation of GrowDex hydrogel–embedded 3D spheroidsBasic Protocol 2: Delivery of siRNA and collection of matrix‐free 3D spheroidsAlternate Protocol 3: Delivery of siRNA and collection of matrix‐embedded spheroidsBasic Protocol 3: RNA and protein extraction from spheroids for characterization of gene knockdown